SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Alumis CEO Jörg Drappa announces that the Phase 2b LUMUS trial for envudeucitinib in systemic lupus erythematosus did not meet primary endpoints in the overall population; however,…
ZEO ScientifiX announced the multidisciplinary faculty for the inaugural ZEO Xperience, a three-day regenerative medicine conference held in Fort Lauderdale, Florida, from October …
Graco Inc. completed the acquisition of Valco Melton for $447 million to expand its capabilities in precision adhesive application. The deal, valued at approximately 14x 2025 adjus…
Profusa issued a senior secured convertible promissory note to Ascent Partners Fund, maturing in September 2027, under a Securities Purchase Agreement.
The company filed an executed version of an amended and restated limited liability company agreement for Florida Energy Pathway, LLC, outlining organizational and governance terms.…
Fervo Energy signed a 396 MW power purchase agreement with Google for Utah's Cape Station site, targeting carbon-free power development in 2028.
Yext reported fiscal 2027 Q2 results with revenue of $111.1 million and an ARR of $440.8 million. The company announced the acquisition of GoShine and released the prototype for Co…
Mooving selected ELECTRA AI's EVE-Ai platform for battery monitoring to ensure safety and efficiency. Iron Horse Acquisition II Corp.'s proposed business combination with ELECTRA A…
Keurig Dr Pepper is selling its stake in Chobani and a Pennsylvania facility for $925 million to support deleveraging and expand its beverage distribution network with Chobani.
Indaptus Therapeutics amended its at-market sales agreement with H.C. Wainwright & Co. for future common stock offerings, replacing its previous nearly four-year-old agreement.
Invivyd appointed Marc Elia as its Chief Executive Officer effective August 30, 2026. The move indicates a significant leadership change expected to influence the company's future …
Upstream Bio, Inc. has announced pivotal Phase 3 development plans for its TSLP antagonist verekitug in severe asthma and CRSwNP. The company aims to initiate both trials in Q1 202…
Adicet Bio reported the completion of a key SLE study for prula-cel, with topline data expected in September 2026. The company also announced FDA clearance for its ADI-212 mCRPC pr…
MiniMed delivered strong Q1 2027 results with net sales of $843 million, aided by U.S. acceleration and robust international growth. The company raised fiscal year organic revenue …
Medtronic reported $9.8 billion in Q1 FY27 revenue and raised organic growth and EPS guidance, driven by broad portfolio strength.
Geotech drilling is underway for the West Susitna Access Road, linking Nova's Estelle Project to a planned refinery. AIDEA authorized the additional $25 million to finish fieldwork…
Institutional holdings report (13F-HR) filed by AGUR PROVIDENT & TRAINING FUNDS MANAGEMENT LTD.
Enovis Corp entered a binding offer to acquire eCential Robotics for €155 million in cash and potential earnouts to bolster its surgical robotics capabilities. The deal will be fun…
Regis Corp reported positive full-year same-store sales and profit, generating $13.1M in cash from operations despite a decline in net income. The company continues to pursue cost-…
RAD will demonstrate SARA and ROSA AI systems at GSX 2026 in Atlanta and present an education session on AI-orchestrated security operations, extending market reach through partner…